Da traduttori professionisti, imprese, pagine web e archivi di traduzione disponibili gratuitamente al pubblico.
248- 101 (ovariecancer),
safety evaluation of tarceva is based on the data from 759 patients treated with at least one 150 mg dose of tarceva monotherapy during phase iii nsclc study br.21, phase ii nsclc study a248-1007, and three phase ii studies in populations other than nsclc: